ArticleMolecular biology reports2026
Exploratory profiling of oxidative stress and hydrogen sulfide synthesis gene expression and sequence variants in gastric cancer patients.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGastric cancer (GC) is one of the leading causes of cancer-related deaths, particularly in early-stage GC, which is frequently asymptomatic, and there are no reliable molecular markers available for diagnosis. PURPOSE: To identify potential candidate genomic biomarkers for GC with respect to genetic variations and expression changes in genes related to hydrogen sulfide (H METHODOLOGY: We included 15 patients with newly diagnosed gastric adenocarcinoma in a paired case-control molecular design based on tumour tissue and adjacent histologically normal gastric mucosa. Biopsy tissues were used to extract genomic DNA and total RNA. Complementary DNA (cDNA) was synthesised, followed by standard polymerase chain reaction, Sanger sequencing, and quantitative real-time polymerase chain reaction analysis. The selected target genes were cystathionine beta-synthase (CBS), cystathionine gamma-lyase (CTH), 3-mercaptopyruvate sulfurtransferase (MPST), catalase (CAT), and glutathione peroxidase 1 (GPX1).
resultsA total of 53 insertion/deletion/duplication variants without amino acid change and 11 predicted amino acid-changing sites plus multiple homozygous substitution variants were identified through sequence variants screening. Most variants were heterozygous and not present in external databases. Common high-frequency variants included CBS 19,430 C > CG, CTH 28400G > GT, CAT 33470G > GA, and changes associated with GPX1613_618delGGCGGC. Expression analysis indicated upregulation of CBS, CAT, and GPX1 (by approximately 1.40-, 1.73-, and 1.93-fold, respectively), downregulation of MPST (3.11-fold), and slight downregulation of CTH.
conclusionSomatic mutations and altered expression of CBS, CTH, MPST, CAT, and GPX1 in GC tissues indicate coordinated remodeling of sulfur metabolism and redox-defence pathways. Nevertheless, the low ROC performance suggests that these genes should not yet be viewed as viable solo diagnostic biomarkers. Instead, they are exploratory molecular signatures and candidate markers that must be validated on larger series of independent patients, matched tumour-normal sequencing, protein/enzyme lateral re-confirmation and functional studies.
Indexed as
Identifiers
42507218What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.